{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:22:10Z","timestamp":1791872530331,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CIRCB","award":["012\/14"],"award-info":[{"award-number":["012\/14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12884-018-2120-7","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T19:50:17Z","timestamp":1545421817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3844-8428","authenticated-orcid":false,"given":"Judith N.","family":"Torimiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubin","family":"Nanfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Takang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude Kalla","family":"Keou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awum Nchenda","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Njefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimbong","family":"Agyingi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irenee","family":"Domkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desire","family":"Takou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Moudourou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Sosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson E.","family":"Mbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,22]]},"reference":[{"key":"2120_CR1","unstructured":"UNAIDS 2017 Progress Report. \n                    www.unaids.org\/en\/resources\n                    \n                  ."},{"key":"2120_CR2","doi-asserted-by":"crossref","unstructured":"Ducancelle A, Abgueguen P, Birguel J, Mansour W, Pivert A, Le Guillou-Guillemette H, Sobnangou JJ, Rameau A. High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North Cameroon. PloS one. 2013;8(11):e80346.","DOI":"10.1371\/journal.pone.0080346"},{"key":"2120_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2393-13-158","volume":"13","author":"NJ Fomulu","year":"2013","unstructured":"Fomulu NJ, Morfaw FL, Torimiro JN, Nana P, Koh MV, William T. Prevalence, correlates and pattern of hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth. 2013;13:158.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2120_CR4","doi-asserted-by":"publisher","unstructured":"Hong-Lin Chen, Man-Li Zha, Ji-Yu Cai, Gang Qin. 2018. Maternal Viral Load and hepatitis B virus mother-to-child transmission risk: A Systematic Review and Meta-analysis. \n                    https:\/\/doi.org\/10.1111\/hepr.13072","DOI":"10.1111\/hepr.13072"},{"issue":"11","key":"2120_CR5","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1471-0528.1980.tb04458.x","volume":"87","author":"VCW Wong","year":"1980","unstructured":"Wong VCW, Lee AKY, Ip HMH. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. BJOG. 1980;87(11):958\u201365.","journal-title":"BJOG"},{"issue":"11","key":"2120_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080346","volume":"8","author":"A Ducancelle","year":"2013","unstructured":"Ducancelle A, Abgueguen P, Birguel J, Mansour W, Pivert A, Le Guillou-Guillemette H, Sobnangou JJ, Rameau A, Huraux JM, Lunel-Fabiani F. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS One. 2013;8(11):e80346. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0080346\n                    \n                  .","journal-title":"PLoS One"},{"issue":"12","key":"2120_CR7","first-page":"1381","volume":"4","author":"J Torimiro","year":"2014","unstructured":"Torimiro J, Monamele GC, Kowo MP, Takou D, Pouokam G-B, Fokam J, Njoya O. Co-infection of. Hepatitis B Virus and Hepatitis Delta Virus in Yaounde-Cameroon Judith Ndongo British Microbiology Research Journal. 2014;4(12):1381\u201391.","journal-title":"Hepatitis B Virus and Hepatitis Delta Virus in Yaounde-Cameroon Judith Ndongo British Microbiology Research Journal"},{"key":"2120_CR8","unstructured":"WHO Progress Report 2015. \n                    https:\/\/www.who.int\/gho\/publications\/world_health_statistics\/2015\/en\/\n                    \n                  ."},{"key":"2120_CR9","unstructured":"Ministry of Public Health Progress Report 2015."},{"issue":"Suppl 1","key":"2120_CR10","doi-asserted-by":"publisher","first-page":"O18","DOI":"10.1186\/1742-4690-5-S1-O18","volume":"5","author":"A Ayouba","year":"2008","unstructured":"Ayouba A, Le Fouler L, Lien TTX, Ly N, Mar\u00e9chal V, V\u00e9ssi\u00e8re A, Kfutwah A, Reynes JM, Menu E, Nerrienet E, Vray M, Fleury H, Barr\u00e9-Sinoussi F. Prevalence of HIV-1 drug resistance mutations in antiretroviral na\u00efve pregnant women from Cambodia, Cameroon, Central African Republic and Vietnam. Retrovirology. 2008;5(Suppl 1):O18. \n                    https:\/\/doi.org\/10.1186\/1742-4690-5-S1-O18\n                    \n                  .","journal-title":"Retrovirology"},{"issue":"5","key":"2120_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1128\/CVI.00483-10","volume":"18","author":"B Sagnia","year":"2011","unstructured":"Sagnia B, Ateba Ndongo F, Ndiang Moyo Tetang S, Ndongo Torimiro J, Cairo C, Domkam I, Agbor G, Mve E, Tocke O, Fouda E, Ouwe Missi Oukem-Boyer O, Colizzi V. Reference values of lymphocyte subsets in healthy, HIV-negative children in Cameroon. Clin Vaccine Immunol. 2011;18(5):790\u20135.","journal-title":"Clin Vaccine Immunol"},{"key":"2120_CR12","unstructured":"https:\/\/www.molecular.abbott\/int\/en\/products\/infectious-disease\/realtime-hiv-1-viral-load\n                    \n                  . Accessed 25 May 2018."},{"key":"2120_CR13","unstructured":"https:\/\/www.qiagen.com\/us\/shop\/sample-technologies\/rna\/viral-rna\/qiaamp-viral-rna-mini-kit\/#orderinginformation\n                    \n                  . Accessed 25 May 2018."},{"key":"2120_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00705-011-0982-3","volume":"156","author":"J Fokam","year":"2011","unstructured":"Fokam J, Salpini R, Santoro MM, Cento V, D\u2019Arrigo R, Gori C, Perno CF, Colizzi V, Nanfack A, Gwom LC, Cappelli G, Takou D. Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon. Arch Virol. 2011;156:1235\u201343.","journal-title":"Arch Virol"},{"key":"2120_CR15","unstructured":"http:\/\/www3.appliedbiosystems.com\/cms\/groups\/mcb_support\/documents\/generaldocuments\/cms_041468.pdf\n                    \n                  . Accessed 25 May 2018."},{"key":"2120_CR16","unstructured":"https:\/\/www.hiv.lanl.gov\/content\/index\n                    \n                  . Accessed 25 May 2018."},{"key":"2120_CR17","unstructured":"https:\/\/hivdb.stanford.edu\/hivdb\/by-sequences\/\n                    \n                  . Accessed 30 March 2018."},{"key":"2120_CR18","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2214-109X(15)00056-X","volume":"3","author":"MI Andersson","year":"2015","unstructured":"Andersson MI, Rajbhandari R, Kew MC, Vento S, Preiser W, Hoepelman AIM, Theron G, Cotton M, Cohn J, Glebe D, Lesi O, Thursz M, Peters M, Chung R, Wiysonge C. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. Lancet Global Health. 2015;3:e358\u20139.","journal-title":"Lancet Global Health"},{"key":"2120_CR19","unstructured":"Bordeaux Call 2018 for the Fight against Viral Hepatitis B and C (\n                    http:\/\/www.afravih2018.org\/appel-de-bordeaux\n                    \n                  ). Accessed 19 May 2018."},{"key":"2120_CR20","unstructured":"Ministry of Public Health Progress Report 2011."},{"issue":"6","key":"2120_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/00365549309008564","volume":"25","author":"PM Ndumbe","year":"1993","unstructured":"Ndumbe PM, Skalsky J. Hepatitis C virus infection in different populations in Cameroon. Scand J Infect Dis. 1993;25(6):689\u201392.","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"2120_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4297\/najms.2011.3238","volume":"3","author":"O Ugbebor","year":"2011","unstructured":"Ugbebor O, Aigbirior M, Osazuwa F, Enabudoso E, Zabayo O. The prevalence of hepatitis B and C viral infections among pregnant women. N Am J Med Sci. 2011;3(5):238\u201341.","journal-title":"N Am J Med Sci"},{"key":"2120_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1743-422X-9-62","volume":"9","author":"AK Kfutwah","year":"2012","unstructured":"Kfutwah AK, Tejiokem MC, Njouom R. A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon. Virol J. 2012;9:62.","journal-title":"Virol J"},{"issue":"3","key":"2120_CR24","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3201\/eid1303.061069","volume":"13","author":"C Laurent","year":"2007","unstructured":"Laurent C, Bourgeois A, Mpoudi M, Butel C, Mpoudi-Ngol\u00e9 E, Delaporte E. HIV and hepatitis C virus coinfection, Cameroon. Emerg Infect Dis. 2007;13(3):514\u20136.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"2120_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1128\/JCM.40.3.837-845.2002","volume":"40","author":"PN Fonjungo","year":"2002","unstructured":"Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Lyonga EJ, Nkengasong JN, Lal RB, Rayfield M, Kalish ML, Folks TM, Pieniazek D. Human immunodeficiency virus type 1 group m protease in Cameroon: genetic diversity and protease inhibitor mutational features. J Clin Microbiol. 2002;40(3):837\u201345.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2120_CR26","first-page":"256","volume":"42","author":"A Vessi\u00e8re","year":"2006","unstructured":"Vessi\u00e8re A, Nerrienet E, Kfutwah A, Menu E, Tejiokem M, Pinson-Recordon P, Barr\u00e9-Sinoussi F, Fleury H, Ayouba A. HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaound\u00e9, Cameroon. JAIDS. 2006;42(2):256\u20138.","journal-title":"JAIDS"},{"issue":"2","key":"2120_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/jmv.21677","volume":"82","author":"ST Burda","year":"2010","unstructured":"Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, Haldar B, Powell RLR, Jarido V, Hewlett IK, Nyambi PN. HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or Na\u00efve to HAART in Cameroon. J Med Virol. 2010;82(2):187\u201396.","journal-title":"J Med Virol"},{"issue":"4","key":"2120_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/aid.2015.0286","volume":"32","author":"CR Courtney","year":"2016","unstructured":"Courtney CR, Agyingi L, Fokou A, Christie S, Asaah B, Meli J, Ngai J, Hewlett I, Nyambi PN. Monitoring HIV-1 Group M Subtypes in Yaound\u00e9, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG\/F2 Infection. AIDS Res Hum Retrovir. 2016;32(4):381\u20135.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"2120_CR29","first-page":"178","volume":"7","author":"GM Ikomey","year":"2017","unstructured":"Ikomey GM, Assoumou MCO, Gichana JO, Njenda D, Mikasi SG, Mesembe M, Lyonga E, Jacobs GB. Observed HIV drug resistance associated mutations amongst na\u00efve immunocompetent children in Yaound\u00e9, Cameroon. Germs. 2017. Dec. 2017;7(4):178\u201385.","journal-title":"Dec"},{"key":"2120_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00634-17JCM.00634-17","volume-title":"Multimethod Longitudinal HIV Drug Resistance Analysis in ART Na\u00efve Patients","author":"AJ Nanfack","year":"2017","unstructured":"Nanfack AJ, Redd AD, Bimela JS, Ncham G, Achem E, Banin AN, Kirk Patrick AR, Porcella SF, Agyingi LA, Meli J, Colizzi V, N\u00e1das A, Gorny MK, Nyambi PN, Quinn TC, Duerr R. Multimethod Longitudinal HIV Drug Resistance Analysis in ART Na\u00efve Patients; 2017. \n                    https:\/\/doi.org\/10.1128\/JCM.00634-17JCM.00634-17\n                    \n                  ."},{"issue":"5","key":"2120_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jmv.23244","volume":"84","author":"L Ceccarelli","year":"2012","unstructured":"Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, Takou D, Nanfack A, Dori L, Torimiro J, Sarmati L, Andreoni M, Perno CF, Colizzi V, Cappelli G. Characterization of drug resistance mutations in na\u00efve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. J Med Virol. 2012;84(5):721\u20137.","journal-title":"J Med Virol"},{"key":"2120_CR32","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1742-4690-10-161","volume":"10","author":"B Titanji","year":"2013","unstructured":"Titanji B, Aasa-Chapman M, Pillay D, Jolly C. Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells. Retrovirology. 2013;10:161. \n                    https:\/\/doi.org\/10.1186\/1742-4690-10-161\n                    \n                  .","journal-title":"Retrovirology"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-018-2120-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-018-2120-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-018-2120-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T19:12:28Z","timestamp":1576955548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-018-2120-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2120"],"URL":"https:\/\/doi.org\/10.1186\/s12884-018-2120-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JNT is an Associate Professor of Molecular Biology and Chair of Department of Biochemistry, and Coordinator of Laboratories in CIRCB who contributed in setting up the Early Infant Diagnosis HIV Programme in Cameroon in 2007; RM (Professor) is a gynaecologist and Director of the Division of Family Health in the Ministry of Public Health; WT (Senior Lecturer) is a gynaecologist, and CKK (Senior Lecturer) is a paediatrician; AJN, KN, KA and SM are clinicians; AN, DT and SS are biologists and ID is a biostatistician.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author\u2019s information"}},{"value":"Approval to carry out this work was given by the Chantal Biya International Reference Centre (CIRCB) Institutional Review Board (IRB), Yaounde, Cameroon. A written informed consent was given by each woman before participation. The laboratory results were given to the women and those who were positive for any of the virus, were referred to care services.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"504"}}